Dr. Reddy's Laboratories, Inc. is recalling 571 vials of Succinylcholine Chloride Injection, USP (200 mg/10 mL). Stability testing at the six-month mark revealed that the concentration of the preservative in the medication had decreased below required specifications. This recall affects multiple-dose vials distributed nationwide across the United States.
A decreased concentration of preservative in a multiple-dose vial may fail to prevent the growth of microorganisms once the vial is opened, potentially leading to infections in patients who receive the injection.
Recall #: D-0008-2026; Rx Only.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.